185 related articles for article (PubMed ID: 25652785)
1. Absorption, elimination and cerebrospinal fluid concentrations of nimodipine in healthy beagle dogs receiving human intravenous and oral formulation.
Koskimäki J; Tarkia M; Ahtola-Sätilä T; Saloranta L; Laakso A; Frantzén J
Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):295-300. PubMed ID: 25652785
[TBL] [Abstract][Full Text] [Related]
2. Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage.
Rämsch KD; Ahr G; Tettenborn D; Auer LM
Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():74-8. PubMed ID: 4010869
[TBL] [Abstract][Full Text] [Related]
3. Simple and validated UHPLC-MS/MS analysis of nimodipine in plasma and cerebrospinal fluid of patients with subarachnoid haemorrhage.
Mohamed S; Riva R; Contin M
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1028():94-99. PubMed ID: 27327399
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization, and pharmacokinetics of sterically stabilized nimodipine-containing liposomes.
Yang D; Zhu J; Zheng Y; Ge L; Zhang G
Drug Dev Ind Pharm; 2006 Feb; 32(2):219-27. PubMed ID: 16537202
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Arterial Hypotension in Patients Receiving Peroral or Continuous Intra-arterial Nimodipine After Aneurysmal or Perimesencephalic Subarachnoid Hemorrhage.
Kieninger M; Gruber M; Knott I; Dettmer K; Oefner PJ; Bele S; Wendl C; Tuemmler S; Graf B; Eissnert C
Neurocrit Care; 2019 Aug; 31(1):32-39. PubMed ID: 30725331
[TBL] [Abstract][Full Text] [Related]
6. Mass spectrometry-based method for quantification of nimodipine and glutamate in cerebrospinal fluid. Pilot study with patients after aneurysmal subarachnoid haemorrhage.
Mindt S; Tokhi U; Hedtke M; Groß HJ; Hänggi D
J Clin Pharm Ther; 2020 Feb; 45(1):81-87. PubMed ID: 31421063
[TBL] [Abstract][Full Text] [Related]
7. Contribution of both olfactory and systemic pathways for brain targeting of nimodipine-loaded lipo-pluronics micelles: in vitro characterization and in vivo biodistribution study after intranasal and intravenous delivery.
Rashed HM; Shamma RN; Basalious EB
Drug Deliv; 2016 Nov; 24(1):181-187. PubMed ID: 28156162
[TBL] [Abstract][Full Text] [Related]
8. Nimodipine: drug pharmacokinetics and plasma adenosine levels in patients affected by cerebral ischemia.
Blardi P; Urso R; De Lalla A; Volpi L; Perri TD; Auteri A
Clin Pharmacol Ther; 2002 Nov; 72(5):556-61. PubMed ID: 12426519
[TBL] [Abstract][Full Text] [Related]
9. Distribution of nimodipine in brain following intranasal administration in rats.
Zhang QZ; Jiang XG; Wu CH
Acta Pharmacol Sin; 2004 Apr; 25(4):522-7. PubMed ID: 15066224
[TBL] [Abstract][Full Text] [Related]
10. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
[TBL] [Abstract][Full Text] [Related]
11. Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain.
Zhang Q; Jiang X; Jiang W; Lu W; Su L; Shi Z
Int J Pharm; 2004 May; 275(1-2):85-96. PubMed ID: 15081140
[TBL] [Abstract][Full Text] [Related]
12. The influence of age on the pharmacokinetics of nimodipine.
Mück W; Breuel HP; Kuhlmann J
Int J Clin Pharmacol Ther; 1996 Jul; 34(7):293-8. PubMed ID: 8832305
[TBL] [Abstract][Full Text] [Related]
13. Intracranial biodegradable silica-based nimodipine drug release implant for treating vasospasm in subarachnoid hemorrhage in an experimental healthy pig and dog model.
Koskimäki J; Tarkia M; Ahtola-Sätilä T; Saloranta L; Simola O; Forsback AP; Laakso A; Frantzén J
Biomed Res Int; 2015; 2015():715752. PubMed ID: 25685803
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
[TBL] [Abstract][Full Text] [Related]
15. Development and pharmacokinetics of nimodipine-loaded liposomes.
Wang Z; Deng Y; Zhang X; Wang T; Wu F
J Pharm Pharmacol; 2006 Sep; 58(9):1289-94. PubMed ID: 16945189
[TBL] [Abstract][Full Text] [Related]
16. A two-step strategy to design high bioavailable controlled-release nimodipine tablets: the push-pull osmotic pump in combination with the micronization/solid dispersion techniques.
Liu X; Wang S; Chai L; Zhang D; Sun Y; Xu L; Sun J
Int J Pharm; 2014 Jan; 461(1-2):529-39. PubMed ID: 24374219
[TBL] [Abstract][Full Text] [Related]
17. Novel self-assembled nano-tubular mixed micelles of Pluronics P123, Pluronic F127 and phosphatidylcholine for oral delivery of nimodipine: In vitro characterization, ex vivo transport and in vivo pharmacokinetic studies.
Basalious EB; Shamma RN
Int J Pharm; 2015 Sep; 493(1-2):347-56. PubMed ID: 26241752
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic intravenous nimodipine treatment in skull base surgery: pharmacokinetic aspects.
Scheller C; Vogel AS; Simmermacher S; Rachinger JC; Prell J; Strauss C; Reinsch M; Kunter U; Wienke A; Neumann J; Scheller K
J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):153-9. PubMed ID: 22241592
[TBL] [Abstract][Full Text] [Related]
19. Grapefruit juice increases oral nimodipine bioavailability.
Fuhr U; Maier-Brüggemann A; Blume H; Mück W; Unger S; Kuhlmann J; Huschka C; Zaigler M; Rietbrock S; Staib AH
Int J Clin Pharmacol Ther; 1998 Mar; 36(3):126-32. PubMed ID: 9562227
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal Fluid Concentrations of Nimodipine Correlate With Long-term Outcome in Aneurysmal Subarachnoid Hemorrhage: Pilot Study.
Riva R; Pegoli M; Contin M; Perrone A; Mohamed S; Zanello M
Clin Neuropharmacol; 2019; 42(5):157-162. PubMed ID: 31306217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
